Cheryl and husband Rob McEwen established the McEwen Centre for Regenerative Medicine at University Health Network in Toronto and already the research has produced amazing results.
An example is the Toronto ExVivo Lung Perfusion System that re-conditions and repairs donated lungs that have to be discarded because they are not good enough for transplant but now can be made suitable for patients. Currently only 15% of donor lungs are suitable for transplantation.
The five-year survival rate of patients who have lung transplants is approximately 50%, significantly worse than the survival rates for heart, liver, or kidney transplants. Research in regenerative medicine at UHN is starting to produce results that are having a global impact on saving lives. As a lung transplant survivor of 11 years this research is of great importance to me and all transplant patients.
had the pleasure of meeting Cheryl and Rob McEwen and was greatly impressed with their passion for improving and saving lives through scientific research.
Cheryl McEwen with Michael Burns